GlassScriptPhysician profile
Rafael Machado
NPI 1811972136
$477.02
in general payments reported to CMS, 2019-2025
10 companies · $108 in 2025
The $108 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.81 · 2021: $71.05 · 2022: $56.16 · 2023: $161 · 2024: $17.64 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $148.57 | 2022-2025 | Mcgrath Mac, Nim-Response, Nellcor |
| Merck Sharp & Dohme LLC | $137.95 | 2019-2025 | Bridion |
| Edwards Lifesciences Corporation | $41.65 | 2021 | |
| Eagle Pharmaceuticals, INC. | $29.60 | 2023 | |
| Abbott Laboratories | $29.34 | 2019 | |
| Masimo Corporation | $27.88 | 2025 | Sedline |
| Octapharma USA, INC. | $18.20 | 2025 | Fibryga |
| Teleflex LLC | $17.21 | 2019 | |
| Mindray Ds USA, INC. | $15.13 | 2023 | A7 Anesthesia System |
| Pacira Pharmaceuticals Incorporated | $11.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Machado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.